Showing results (131-140 of 204) with videos related to
Sort By:
Pageof 21
Journal of Cellular Physiology|July 11, 2012
Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: growth inhibition, quiescence, and recoveryBrian I Carr, Aldo Cavallini, Catia Lippolis, et al.Journal of Clinical Medicine|May 4, 2026
HALP Score in Predicting Post-Liver Transplant Outcomes in Patients with Hepatocellular CarcinomaSertac Usta, Fuat Aksoy, Yasin Dalda, et al.Clinical Practice (London, England)|August 25, 2023
Identification of 2 large size HCC phenotypes, with and without associated inflammationBrian I Carr, Harika Gozukara Bag, Hikmet Akkiz, et al.Clinical Practice (London, England)|May 11, 2021
CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantationBrian I Carr, Volkan Ince, Harika Gozukara Bag, et al.Medeniyet Medical Journal|March 21, 2024
The Course of Endoscopic Treatment Success in Biliary Complications After Living Donor Liver TransplantationEngin Ataman, Murat Harputluoglu, Yilmaz Bilgic, et al.Anti-Cancer Agents in Medicinal Chemistry|June 18, 2014
Modulation of Doxorubicin mediated growth inhibition of hepatocellular carcinoma cells by platelet lysatesMaria Grazia Refolo, Rosalba D'Alessandro, Catia Lippolis, et al.The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|September 8, 2023
Liver Transplantation for Hepatocellular Carcinoma in Patients with Inherited Metabolic Liver Diseases: A Single-Center Analysisİbrahim Umar Garzali, Abdirahman Sakulen Hargura, Volkan İnce, et al.Journal of Gastroenterology and Hepatology|May 15, 2015
Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patientsAntonio Facciorusso, Valentina Del Prete, Nicola Crucinio, et al.Journal of Gastrointestinal Cancer|November 15, 2012
Systemic treatment of gastrointestinal cancer in elderly patientsSilvana Leo, Caterina Accettura, Antonio Gnoni, et al.Cancer|February 6, 2003
Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinomaOsama M Ebied, Michael P Federle, Brian I Carr, et al.Pageof 21